Iron (III) isomaltoside 1000 (Monover®)

Assessment Status Rapid Review Complete
Drug Iron (III) isomaltoside 1000
Brand Monover®
Indication For the treatment of Iron deficiency anaemia when oral iron preparations are ineffective or cannot be used or where there is a clinical need to deliver iron rapidly.
Assessment Process
Rapid review commissioned 10/10/2015
Rapid review completed 18/11/2015
Rapid review outcome Full Pharmacoeconomic Assessment Not Recommended